rxstatShortages › Amlodipine Telmisartan

Amlodipine Telmisartan shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Amlodipine Telmisartan products are in shortage in Canada (2 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
2 of 6
Reports on file
28
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
AA-TELMISARTAN-AMLODIPINE
10MG 80MG · TABLET · AA PHARMA INC
DIN 02473496 · since ?, no end estimate · Disruption of the manufacture of the drug.
Active shortage
AA-TELMISARTAN-AMLODIPINE
5MG 80MG · TABLET · AA PHARMA INC
DIN 02473488 · since ?, no end estimate · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
5MG 40MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371022 · ended Feb 20, 2026 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
10MG 80MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371057 · ended Feb 13, 2026 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
5MG 80MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371049 · ended Feb 16, 2023 · Demand increase for the drug.
Resolved
TWYNSTA
10MG 80MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371057 · ended Nov 14, 2022 · Demand increase for the drug.
Resolved
TWYNSTA
80MG 5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371049 · ended Feb 26, 2021 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
80MG 10MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371057 · ended Jan 28, 2021 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
40MG 5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371022 · ended Jan 15, 2021 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
80MG 10MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371057 · ended Dec 17, 2020 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
40MG 5MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371022 · ended Dec 16, 2020 · Disruption of the manufacture of the drug.
Resolved
TWYNSTA
40MG 10MG · TABLET · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02371030 · ended Nov 13, 2020 · Disruption of the manufacture of the drug.

Showing 12 of 28 reports. All reports are on file with Health Canada.

What's happening

Amlodipine Telmisartan is currently affected by 2 active shortage reports filed with Health Canada by AA PHARMA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Amlodipine Telmisartan is classified under “ANGIOTENSIN II ANTAGONISTS, COMBINATIONS” (ATC C09DB).

Recent changes

Common questions

When will Amlodipine Telmisartan be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Amlodipine Telmisartan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (angiotensin ii antagonists, combinations)

All angiotensin ii antagonists, combinations shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.